Echogenicity as a surrogate for bioresorbable everolimus-eluting scaffold degradation: analysis at 1-, 3-, 6-, 12- 18, 24-, 30-, 36- and 42-month follow-up in a porcine model

International Journal of Cardiovascular Imaging

Volumn 31, Issue 3, 2015, Pages 471-482

  Campos, Carlos M ^a,b   Ishibashi, Yuki ^a   Eggermont, Jeroen ^c   Nakatani, Shimpei ^a   Cho, Yun Kyeong ^a   Dijkstra, Jouke ^c   Reiber, Johan H C ^c   Sheehy, Alexander ^e   Lane, Jennifer ^e   Kamberi, Marika ^e   Rapoza, Richard ^e   Perkins, Laura ^e   Garcia Garcia, Hector M ^a,d   Onuma, Yoshinobu ^a   Serruys, Patrick W ^a,f  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d CARDIALYSIS   (Netherlands)

^e ABBOTT VASCULAR   (United States)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Absorb; Bioresorbable vascular scaffold; Degradation; Echogenicity; IVUS; Porcine

Indexed keywords

CARDIOVASCULAR AGENT; EVEROLIMUS; LACTIC ACID; POLYLACTIC ACID; POLYMER;

ANIMAL; ANIMAL MODEL; BIODEGRADABLE IMPLANT; CHEMISTRY; CORONARY BLOOD VESSEL; CRYSTALLIZATION; DEVICES; DRUG ELUTING STENT; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; OBSERVER VARIATION; PIG; PREDICTIVE VALUE; PROSTHESIS; REPRODUCIBILITY; STATISTICAL MODEL; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; VALIDATION STUDY;

ABSORBABLE IMPLANTS; ANGIOPLASTY, BALLOON, CORONARY; ANIMALS; CARDIOVASCULAR AGENTS; CORONARY VESSELS; CRYSTALLIZATION; DRUG-ELUTING STENTS; EVEROLIMUS; LACTIC ACID; LINEAR MODELS; MODELS, ANIMAL; OBSERVER VARIATION; POLYMERS; PREDICTIVE VALUE OF TESTS; PROSTHESIS DESIGN; REPRODUCIBILITY OF RESULTS; SWINE; TIME FACTORS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84925456992     PISSN: 15695794     EISSN: 15730743     Source Type: Journal    
DOI: 10.1007/s10554-015-0591-4     Document Type: Article

References (40)

1. Iqbal J, Onuma Y, Ormiston J, Abizaid A, Waksman R, Serruys P (2013) Bioresorbable scaffolds: rationale, current status, challenges, and future. Eur Heart J
2. Wykrzykowska JJ, Onuma Y, Serruys PW (2009) Vascular restoration therapy: the fourth revolution in interventional cardiology and the ultimate “rosy” prophecy. EuroIntervention 5 Suppl F:F7-F8
3. Garcia-Garcia HM, Serruys PW, Campos CM, Muramatsu T, Nakatani S, Zhang YJ, Onuma Y, Stone GW (2014) Assessing Bioresorbable Coronary Devices: Methods and Parameters. JACC Cardiovasc Imaging 7:1130–1148
4. Campos CM, Muramatsu T, Iqbal J, Zhang YJ, Onuma Y, Garcia-Garcia HM, Haude M, Lemos PA, Warnack B, Serruys PW (2013) Bioresorbable drug-eluting magnesium-alloy scaffold for treatment of coronary artery disease. Int J Mol Sci 14:24492–24500
5. Campos CM, Lemos PA (2014) Bioresorbable vascular scaffolds: novel devices, novel interpretations, and novel interventions strategies. Catheter Cardiovasc Interv 84:46–47
6. Garcia-Garcia HM, Gonzalo N, Pawar R, Kukreja N, Dudek D, Thuesen L, Ormiston JA, Regar E, Serruys PW (2009) Assessment of the absorption process following bioabsorbable everolimus-eluting stent implantation: temporal changes in strain values and tissue composition using intravascular ultrasound radiofrequency data analysis. A substudy of the ABSORB clinical trial. EuroIntervention 4:443–448
7. Bruining N, de Winter S, Roelandt JR, Regar E, Heller I, van Domburg RT, Hamers R, Onuma Y, Dudek D, Webster MW, Thuesen L, Ormiston JA, Cheong WF, Miquel-Hebert K, Veldhof S, Serruys PW (2010) Monitoring in vivo absorption of a drug-eluting bioabsorbable stent with intravascular ultrasound-derived parameters a feasibility study. JACC Cardiovasc Interv 3:449–456
8. Waksman R, Prati F, Bruining N, Haude M, Bose D, Kitabata H, Erne P, Verheye S, Degen H, Vermeersch P, Di Vito L, Koolen J, Erbel R (2013) Serial observation of drug-eluting absorbable metal scaffold: multi-imaging modality assessment. Circ Cardiovasc Interv 6:644–653
9. Bruining N, Verheye S, Knaapen M, Somers P, Roelandt JR, Regar E, Heller I, de Winter S, Ligthart J, Van Langenhove G, de Feijter PJ, Serruys PW, Hamers R (2007) Three-dimensional and quantitative analysis of atherosclerotic plaque composition by automated differential echogenicity. Catheter Cardiovasc Interv 70:968–978
10. Puri R, Libby P, Nissen SE, Wolski K, Ballantyne CM, Barter PJ, Chapman MJ, Erbel R, Raichlen JS, Uno K, Kataoka Y, Tuzcu EM, Nicholls SJ (2014) Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN. Eur Heart J Cardiovasc Imaging 15:380–388
11. Nozue T, Fukui K, Yamamoto S, Kunishima T, Umezawa S, Onishi Y, Tohyama S, Hibi K, Sozu T, Terashima M, Michishita I (2013) Time course of statin-induced changes in coronary atherosclerosis using intravascular ultrasound with virtual histology. Coron Artery Dis 24:481–486
12. Zhao Z, Witzenbichler B, Mintz GS, Jaster M, Choi SY, Wu X, He Y, Margolis MP, Dressler O, Cristea E, Parise H, Mehran R, Stone GW, Maehara A (2013) Dynamic nature of nonculprit coronary artery lesion morphology in STEMI: a serial IVUS analysis from the HORIZONS-AMI trial. JACC Cardiovasc Imaging 6:86–95
13. Hattori K, Ozaki Y, Ismail TF, Okumura M, Naruse H, Kan S, Ishikawa M, Kawai T, Ohta M, Kawai H, Hashimoto T, Takagi Y, Ishii J, Serruys PW, Narula J (2012) Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS. JACC Cardiovasc Imaging 5:169–177
14. Lee IS, Bourantas CV, Muramatsu T, Gogas BD, Heo JH, Diletti R, Farooq V, Zhang Y, Onuma Y, Serruys PW, Garcia-Garcia HM (2013) Assessment of plaque evolution in coronary bifurcations located beyond everolimus eluting scaffolds: serial intravascular ultrasound virtual histology study. Cardiovasc Ultrasound. 11:25
15. Serruys PW, Onuma Y, Dudek D, Smits PC, Koolen J, Chevalier B, de Bruyne B, Thuesen L, McClean D, van Geuns RJ, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Hebert KM, Sudhir K, Garcia-Garcia HM, Ormiston JA (2011) Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes. J Am Coll Cardiol 58:1578–1588
16. Serruys PW, Onuma Y, Garcia-Garcia HM, Muramatsu T, van Geuns RJ, de Bruyne B, Dudek D, Thuesen L, Smits PC, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Hebert KM, Rapoza R, Ormiston JA (2013) Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months. EuroIntervention
17. Serruys PW, Onuma Y, Ormiston JA, de Bruyne B, Regar E, Dudek D, Thuesen L, Smits PC, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Miquel-Hebert K, Rapoza R, Garcia-Garcia HM (2010) Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Circulation 122:2301–2312
18. Lane JP, Perkins LE, Sheehy AJ, Pacheco EJ, Frie MP, Lambert BJ, Rapoza RJ, Virmani R (2014) Lumen gain and restoration of pulsatility after implantation of a bioresorbable vascular scaffold in porcine coronary arteries. JACC Cardiovasc Interv
19. Onuma Y, Serruys PW, Perkins LE, Okamura T, Gonzalo N, Garcia-Garcia HM, Regar E, Kamberi M, Powers JC, Rapoza R, van Beusekom H, van der Giessen W, Virmani R (2010) Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial. Circulation 122:2288–2300
20. Fleiss JL (ed) (1986) The design and analysis of clinical experiments. Wiley, New York
21. Rasheed Q, Dhawale PJ, Anderson J, Hodgson JM (1995) Intracoronary ultrasound-defined plaque composition: computer-aided plaque characterization and correlation with histologic samples obtained during directional coronary atherectomy. Am Heart J 129:631–637
22. Schartl M, Bocksch W, Koschyk DH, Voelker W, Karsch KR, Kreuzer J, Hausmann D, Beckmann S, Gross M (2001) Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease. Circulation 104:387–392
23. Sathyanarayana S, Carlier S, Li W, Thomas L (2009) Characterisation of atherosclerotic plaque by spectral similarity of radiofrequency intravascular ultrasound signals. EuroIntervention 5:133–139
24. Nair A, Kuban BD, Tuzcu EM, Schoenhagen P, Nissen SE, Vince DG (2002) Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 106:2200–2206
25. Nair A, Margolis MP, Kuban BD, Vince DG (2007) Automated coronary plaque characterisation with intravascular ultrasound backscatter: ex vivo validation. EuroIntervention 3:113–120
26. Okubo M, Kawasaki M, Ishihara Y, Takeyama U, Kubota T, Yamaki T, Ojio S, Nishigaki K, Takemura G, Saio M, Takami T, Minatoguchi S, Fujiwara H (2008) Development of integrated backscatter intravascular ultrasound for tissue characterization of coronary plaques. Ultrasound Med Biol 34:655–663
27. Otsu N (1979) A threshold selection method from gray-level histograms. IEEE Transactions on Systems, Man and Cybernetics 9:62–66
28. Santos Filho ESY, Tanaka A, Yoshizawa M (2008) Detection and quantification of calcifications in intravascular ultrasound images by automatic thresholding. Ultrasound Med Biol 34:160–165
29. Koning G, Dijkstra J, von Birgelen C, Tuinenburg JC, Brunette J, Tardif JC (2002) Advanced contour detection for three-dimensional intracoronary ultrasound: a validation–in vitro and in vivo. Int J Cardiovasc Imag 18:235–248
30. Mintz GS, Garcia-Garcia HM, Nicholls SJ, Weissman NJ, Bruining N, Crowe T, Tardif JC, Serruys PW (2011) Clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound regression/progression studies. EuroIntervention 6(1123–30):9
31. Wu HC, Shen FW, Hong X, Chang WV, Winet H (2003) Monitoring the degradation process of biopolymers by ultrasonic longitudinal wave pulse-echo technique. Biomaterials 24:3871–3876
32. Parker NG, Mather ML, Morgan SP, Povey MJ (2010) Longitudinal acoustic properties of poly(lactic acid) and poly(lactic-co-glycolic acid). Biomed Mater 5:055004
33. Chen S, Hong Y, Scherer SJ, Schartl M (2001) Lack of ultraviolet-light inducibility of the medakafish (Oryzias latipes) tumor suppressor gene p53. Gene 264:197–203
34. Sarno G, Onuma Y, Garcia Garcia HM, Garg S, Regar E, Thuesen L, Dudek D, Veldhof S, Dorange C, Ormiston JA, Serruys PW (2010) IVUS radiofrequency analysis in the evaluation of the polymeric struts of the bioabsorbable everolimus-eluting device during the bioabsorption process. Catheter Cardiovasc Interv 75:914–918
35. Brugaletta S, Gomez-Lara J, Serruys PW, Farooq V, van Geuns RJ, Thuesen L, Dudek D, Koolen J, Chevalier B, McClean D, Windecker S, Smits PC, de Bruyne B, Whitbourn R, Meredith I, van Domburg RT, Sihan K, de Winter S, Veldhof S, Miquel-Hebert K, Rapoza R, Garcia-Garcia HM, Ormiston JA, Bruining N (2011) Serial in vivo intravascular ultrasound-based echogenicity changes of everolimus-eluting bioresorbable vascular scaffold during the first 12 months after implantation insights from the ABSORB B trial. JACC Cardiovasc Interv 4:1281–1289
36. Brugaletta S, Gomez-Lara J, Garcia-Garcia HM, Heo JH, Farooq V, van Geuns RJ, Chevalier B, Windecker S, McClean D, Thuesen L, Whitbourn R, Meredith I, Dorange C, Veldhof S, Rapoza R, Ormiston JA, Serruys PW (2012) Analysis of 1 year virtual histology changes in coronary plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold. Int J Cardiovasc Imaging 28:1307–1314
37. Henton DE, Gruber P, Lunt J, Randall J (2005) Polylactic acid technology. CRC Press, Boca Raton
38. Vorpahl M, Finn AV, Nakano M, Virmani R (2009) The bioabsorption process: tissue and cellular mechanisms and outcomes. EuroIntervention 5(Suppl F):F28–F35
39. Strandberg E, Zeltinger J, Schulz DG, Kaluza GL (2012) Late positive remodeling and late lumen gain contribute to vascular restoration by a non-drug eluting bioresorbable scaffold: a four-year intravascular ultrasound study in normal porcine coronary arteries. Circ Cardiovasc Interv 5:39–46
40. Durand E, Sharkawi T, Leclerc G, Raveleau M, van der Leest M, Vert M, Lafont A (2013) Head-to-head comparison of a drug-free early programmed dismantling polylactic acid bioresorbable scaffold and a metallic stent in the porcine coronary artery: six-month angiography and optical coherence tomographic follow-up study. Circ Cardiovasc Interv